TFEB and neoplasm: Interestingly, hyperactivation of TFEB in FLCN-deficient or glutamine-deprived DCs results in impaired priming of T cells (Guo et al., 2023), whereas TAMs require increased TFEB and TFE3 activity to impair tumor growth (Zhang et al., 2023).